MedTrace Logo

Study of Dr. Pyke's Supplement for Stream (S4S) in Men With Prostatism and ED

NCT03681392 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-12-20

No results posted yet for this study

Summary

This is the first clinical trial of Dr. Pyke's Supplement for Stream (S4S), a proprietary combination of Panax ginseng extract, L-citrulline, beta-sitosterol and vitamin D3, to investigate its effects on prostatism and erections, and its tolerability, when taken daily and twice-daily for 2 weeks.

Conditions

Interventions

DIETARY_SUPPLEMENT

Dr. Pyke's Supplement for Stream (S4S)

Proprietary combination of Panax ginseng extract, L-citrulline, beta-sitosterol and vitamin D3

Sponsors & Collaborators

  • Robert E. Pyke

    lead INDUSTRY

Principal Investigators

  • Robert E Pyke, MD, PhD · Pykonsult LLC

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-12-31
Completion
2023-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03681392 on ClinicalTrials.gov